Avience Biomedicals
add_icon

Avience Biomedicals

285.85
+8.10
(2.92%)
Market Cap
156.79 Cr
PE Ratio
26.55
Volume
33,000.00
Day High - Low
287.00 - 268.50
52W High-Low
414.95 - 208.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
156.79 Cr
EPS
14.24
PE Ratio
26.55
PB Ratio
1.74
Book Value
159.61
EBITDA
10.34
Dividend Yield
0.00 %
Industry
-
Sector
-
Return on Equity
31.33
Debt to Equity
1.29
Forecast For
Actual
Growth Rate
Revenue Growth
-8.85 %
Net Income Growth
-19.30 %
Cash Flow Change
232.35 %
ROE
-9.63 %
ROCE
19.47 %
EBITDA Margin (Avg.)
-6.81 %

Yearly Financial Results

Annual Financials
2024
2025
2026
TTM
Revenue
24
46
42
0
Expenses
20
34
32
0
EBITDA
5
12
10
0
Operating Profit %
17 %
25 %
25 %
0 %
Depreciation
1
1
1
0
Interest
1
1
2
0
Profit Before Tax
3
10
8
0
Tax
1
3
2
0
Net Profit
2
7
6
0
EPS in ₹
6.57
17.61
14.24
0.00

Balance Sheet

Balance Sheet
2024
2025
2026
Total Assets
35
57
66
Fixed Assets
10
13
26
Current Assets
23
37
39
Capital Work in Progress
0
5
11
Investments
0
0
16
Other Assets
24
39
0
Total Equity & Liabilities
35
57
66
Current Liabilities
21
24
25
Non Current Liabilities
8
10
12
Total Equity
6
23
29
Reserve & Surplus
3
19
25
Share Capital
3
4
4

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
4
Investing Activities
-4
-10
Operating Activities
1
3
Financing Activities
3
10

Share Holding

% Holding
Dec 2024
Jul 2025
Jun 2026
Promoter
92.85 %
92.85 %
64.59 %
FIIs
0.00 %
0.00 %
3.06 %
DIIs
0.00 %
0.00 %
9.08 %
Government
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
13.57 %
Others
7.15 %
7.15 %
9.69 %
No of Share Holders
33
37
38

Technical Indicators

RSI(14)
Oversold
0.00
ATR(14)
Volatile
0.00
STOCH(9,6)
0.00
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
0.00
WillR(14)
Overbought
0.00